CoreMedic announced that it picked up new funding in a Series B extension to support its transcatheter mitral valve repair ...

With new transcatheter options for the repair or replacement of tricuspid valves, the role and timing of repair — whether surgical or minimally invasive — is entering a time of transition.

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024.

With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.

Beyond surgical excellence, St. Elizabeth prioritizes a highly specialized and patient-focused approach to cardiac care.

Navi Mumbai: A 78-year-old patient with severe mitral regurgitation has successfully undergone the MitraClip procedure, marking a significant advancement in minimally invasive heart care. The rare and ...

Edwards Lifesciences had a higher profit and sales in its fourth quarter as demand for its products held strong. The medical-technology company posted a profit of $385.6 million, or 65 cents a share, ...

February is Heart Month, an effort to raise awareness of heart disease, the leading cause of death for both men and women.

Now Nick and Janelle – who both grew up in Sudbury – are national ambassadors for the Heart and Stroke Foundation's February Heart Month campaign. "Now we're able to help and, and bring awareness to ...

Q. I have a leaky heart valve that may need surgery down the road. Can you tell me about heart-valve surgery in one of your columns? A. First, let’s explain briefly how the heart works.

IRVINE, Calif. - Edwards Lifesciences (NYSE:EW) reported fourth quarter earnings and revenue that beat analyst expectations, sending its shares up 4.2% in after-hours trading on Tuesday.